Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105. (Q33555813)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105. |
scientific article |
Statements
1 reference
Relative contribution of VEGF and TNF-alpha in the cynomolgus laser-induced CNV model: comparing the efficacy of bevacizumab, adalimumab, and ESBA105. (English)
1 reference
Peter Lichtlen
1 reference
Tim T Lam
1 reference
T Michael Nork
1 reference
Tim Streit
1 reference
David M Urech
1 reference
1 reference
Identifiers
1 reference